Neil Cataldi from Blueprint on Sanara Medtech $SMTI episode artwork

EPISODE · May 3, 2021 · 1H 13M

Neil Cataldi from Blueprint on Sanara Medtech $SMTI

from Yet Another Value Podcast · host Andrew Walker

Neil Cataldi from Blueprint Capital discusses his investment thesis for Sanara Medtech (SMTI). Sanara is growing quickly, and Neil thinks continued growth in their product portfolio and hospitals they are approved to sell in will drive continued accelerated growth and long term compounding.Chapters0:00 Intro1:00 Sanara overview5:30 How is Sanara increasing their hospital reach?14:25 Discussing management21:10 Related party risks33:20 Breaking down SMTI's growth42:45 Sanara's telehealth ambitions1:01:10 Closing thoughts

Episode metadata supplied by the publisher feed · Published May 3, 2021

Embed this episode

Ready to play

Neil Cataldi from Blueprint on Sanara Medtech $SMTI

0:00 1:13:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Yet Another Value Podcast?

This episode is 1 hour and 13 minutes long.

When was this Yet Another Value Podcast episode published?

This episode was published on May 3, 2021.

Can I download this Yet Another Value Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!